Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue

D. S. Colvard, W. R. Jankus, N. J. Berg, M. L. Graham, N. S. Jiang, J. N. Ingle, T. C. Spelsberg

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A micro version of a nuclear binding assay to assess the biological activity of receptors for steroid hormones was developed for application to small (needle) biopsies of human tumors for the purpose of predicting responses to steroid therapy. This easier assay requires 10-fold less tissue than the original nuclear binding assay described for progesterone receptors in the avian oviduct, endometrium, and endometrial carcinomas (Spelsberg T.C., et al., Endocrinology 1987; 121:631). We describe the application of this micro assay to normal avian oviduct and cancers of the human breast, and we demonstrate a tissue specificity and saturation of nuclear binding. The micro assay reliably measured as little as 0.5 mg equivalents of tissue per assay tube. Results for breast tumors determined to be estrogen-receptor-positive by the standard dextran-coated charcoal method were also determined with this nuclear binding assay. As described previously for progesterone receptors in endometrial carcinomas, some receptor-positive breast biopsies displayed negligible capacity for nuclear binding. Therefore, with the present assay we have identified nonfunctional receptors in these biopsies, which may be useful for accurate prediction of patients' responses to therapy with hormones.

Original languageEnglish (US)
Pages (from-to)363-369
Number of pages7
JournalClinical Chemistry
Volume34
Issue number2
StatePublished - 1988

Fingerprint

Oviducts
Steroid Receptors
Progesterone Receptors
Endometrial Neoplasms
Assays
Hormones
Tissue
Breast Neoplasms
Biopsy
Organ Specificity
Endocrinology
Charcoal
Needle Biopsy
Endometrium
Dextrans
Estrogen Receptors
Breast
Steroids
Therapeutics
Tumors

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Colvard, D. S., Jankus, W. R., Berg, N. J., Graham, M. L., Jiang, N. S., Ingle, J. N., & Spelsberg, T. C. (1988). Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue. Clinical Chemistry, 34(2), 363-369.

Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue. / Colvard, D. S.; Jankus, W. R.; Berg, N. J.; Graham, M. L.; Jiang, N. S.; Ingle, J. N.; Spelsberg, T. C.

In: Clinical Chemistry, Vol. 34, No. 2, 1988, p. 363-369.

Research output: Contribution to journalArticle

Colvard, DS, Jankus, WR, Berg, NJ, Graham, ML, Jiang, NS, Ingle, JN & Spelsberg, TC 1988, 'Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue', Clinical Chemistry, vol. 34, no. 2, pp. 363-369.
Colvard, D. S. ; Jankus, W. R. ; Berg, N. J. ; Graham, M. L. ; Jiang, N. S. ; Ingle, J. N. ; Spelsberg, T. C. / Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue. In: Clinical Chemistry. 1988 ; Vol. 34, No. 2. pp. 363-369.
@article{a514c76765a14c33a592301f29512529,
title = "Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue",
abstract = "A micro version of a nuclear binding assay to assess the biological activity of receptors for steroid hormones was developed for application to small (needle) biopsies of human tumors for the purpose of predicting responses to steroid therapy. This easier assay requires 10-fold less tissue than the original nuclear binding assay described for progesterone receptors in the avian oviduct, endometrium, and endometrial carcinomas (Spelsberg T.C., et al., Endocrinology 1987; 121:631). We describe the application of this micro assay to normal avian oviduct and cancers of the human breast, and we demonstrate a tissue specificity and saturation of nuclear binding. The micro assay reliably measured as little as 0.5 mg equivalents of tissue per assay tube. Results for breast tumors determined to be estrogen-receptor-positive by the standard dextran-coated charcoal method were also determined with this nuclear binding assay. As described previously for progesterone receptors in endometrial carcinomas, some receptor-positive breast biopsies displayed negligible capacity for nuclear binding. Therefore, with the present assay we have identified nonfunctional receptors in these biopsies, which may be useful for accurate prediction of patients' responses to therapy with hormones.",
author = "Colvard, {D. S.} and Jankus, {W. R.} and Berg, {N. J.} and Graham, {M. L.} and Jiang, {N. S.} and Ingle, {J. N.} and Spelsberg, {T. C.}",
year = "1988",
language = "English (US)",
volume = "34",
pages = "363--369",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "2",

}

TY - JOUR

T1 - Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue

AU - Colvard, D. S.

AU - Jankus, W. R.

AU - Berg, N. J.

AU - Graham, M. L.

AU - Jiang, N. S.

AU - Ingle, J. N.

AU - Spelsberg, T. C.

PY - 1988

Y1 - 1988

N2 - A micro version of a nuclear binding assay to assess the biological activity of receptors for steroid hormones was developed for application to small (needle) biopsies of human tumors for the purpose of predicting responses to steroid therapy. This easier assay requires 10-fold less tissue than the original nuclear binding assay described for progesterone receptors in the avian oviduct, endometrium, and endometrial carcinomas (Spelsberg T.C., et al., Endocrinology 1987; 121:631). We describe the application of this micro assay to normal avian oviduct and cancers of the human breast, and we demonstrate a tissue specificity and saturation of nuclear binding. The micro assay reliably measured as little as 0.5 mg equivalents of tissue per assay tube. Results for breast tumors determined to be estrogen-receptor-positive by the standard dextran-coated charcoal method were also determined with this nuclear binding assay. As described previously for progesterone receptors in endometrial carcinomas, some receptor-positive breast biopsies displayed negligible capacity for nuclear binding. Therefore, with the present assay we have identified nonfunctional receptors in these biopsies, which may be useful for accurate prediction of patients' responses to therapy with hormones.

AB - A micro version of a nuclear binding assay to assess the biological activity of receptors for steroid hormones was developed for application to small (needle) biopsies of human tumors for the purpose of predicting responses to steroid therapy. This easier assay requires 10-fold less tissue than the original nuclear binding assay described for progesterone receptors in the avian oviduct, endometrium, and endometrial carcinomas (Spelsberg T.C., et al., Endocrinology 1987; 121:631). We describe the application of this micro assay to normal avian oviduct and cancers of the human breast, and we demonstrate a tissue specificity and saturation of nuclear binding. The micro assay reliably measured as little as 0.5 mg equivalents of tissue per assay tube. Results for breast tumors determined to be estrogen-receptor-positive by the standard dextran-coated charcoal method were also determined with this nuclear binding assay. As described previously for progesterone receptors in endometrial carcinomas, some receptor-positive breast biopsies displayed negligible capacity for nuclear binding. Therefore, with the present assay we have identified nonfunctional receptors in these biopsies, which may be useful for accurate prediction of patients' responses to therapy with hormones.

UR - http://www.scopus.com/inward/record.url?scp=0023857901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023857901&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 363

EP - 369

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 2

ER -